Predictors of duloxetine adherence and persistence in patients with fibromyalgia by Cui Z, Zhao Y, Novick D, Faries D

Get full text

Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy. by Isenberg, D, Rowe, D, Shearer, M, Novick, D, Beverley, P

Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Databa... by Reed C, Hong J, Novick D, Lenox-Smith A, Happich M

Get full text

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study by Novick D, Montgomery W, Vorstenbosch E, Moneta MV, Dueñas H, Haro JM

Get full text

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia by Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM

Get full text

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care by Andrews JS, Wu N, Chen SY, Yu X, Peng XM, Novick D

Get full text

Antidepressant medication treatment patterns in Asian patients with major depressive disorder by Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM

Get full text

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder by Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM

Get full text

HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjogren's syndrome. by Rowe, D, Griffiths, M, Stewart, J, Novick, D, Beverley, P, Isenberg, D

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity? by Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM

Get full text

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection by Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H

Get full text

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting by Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM

Get full text

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline by Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR

Get full text